Christopher Zimmer

Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure

John E. Blair, Faı̈ez Zannad, Marvin A. Konstam et al. · Journal of the American College of Cardiology · 2008 · 175 citations

Medicine, Cardiology, Internal Medicine +15

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

Mihai Gheorghiade, Cesare Orlandi, John C. Burnett et al. · Journal of Cardiac Failure · 2005 · 172 citations

Medicine, Cardiology, Pharmacology +12

Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction

James E. Udelson, Frank McGrew, Enrique Flores et al. · Journal of the American College of Cardiology · 2007 · 162 citations

Medicine, Cardiology, Pharmacology +15

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction

James E. Udelson, Martin Bilsker, Paul J. Hauptman et al. · Journal of Cardiac Failure · 2011 · 98 citations

Medicine, Cardiology, Pharmacology +13

Effects of tolvaptan on dyspnoea relief from the EVEREST trials

Peter S. Pang, Marvin A. Konstam, H. B. Krasa et al. · European Heart Journal · 2009 · 76 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16